Madelaine Feldman(@MattieRheumMD) 's Twitter Profileg
Madelaine Feldman

@MattieRheumMD

All opinions are my own and do not reflect those of CSRO-Rheumatologist, Lecture on PBMs, & their part in drug access & pricing-Passion still ahead of cynicism

ID:33318919

calendar_today19-04-2009 21:39:02

4,8K Tweets

2,8K Followers

2,0K Following

Madelaine Feldman(@MattieRheumMD) 's Twitter Profile Photo

Clear to independent observers the major health insurers are merely a group of for profit centers feeding off of everyone, pts needing care suffer the most. Love the review of Karen Lynch’s book- “inspiring story of a woman who makes $54,000 a day denying people life saving care”

account_circle
Angus Worthing MD(@AngusWorthing) 's Twitter Profile Photo

Great piece by Dr Gewanter explaining why state boards to control drug prices won't help, and might hurt people with chronic disease. Real solution: reform, formulary coverage based on science not profit!

account_circle
Angus Worthing MD(@AngusWorthing) 's Twitter Profile Photo

The American drug middleman got ratioed & turned off replies to this post because it's just NOT a ' ' that save money. Each dollar of their rebates siphons $ from health care & raises drug prices, while they restrict pharmacy choice & abuse pharmacists. Time for reform!

account_circle
Madelaine Feldman(@MattieRheumMD) 's Twitter Profile Photo

Clear example of shareholders deciding what drug this psychiatrist can take for his psoriatic arthritis.More evidence that health insurance should be a public utility. Best part is the earnings call! thefrontierpsychiatrists.substack.com/p/dear-carelon…

account_circle
Madelaine Feldman(@MattieRheumMD) 's Twitter Profile Photo

As long as health ins cos/PBMs are publicly traded for-profit cos, OF COURSE they are going choose the most profitable drug (highest price) Until profit is taken out of health ins, none of this is surprising. We can't make them choose to make less money.

account_circle
Madelaine Feldman(@MattieRheumMD) 's Twitter Profile Photo

Truer words were never spoken. Patients going into billions of dollars in debt in order to create the billions of dollars of profits for health insurance cos. The big ins/PBM cos are much higher on Fortune 500 then any pharma co. Regulators/legislators take off the blinders.

account_circle
CSRO(@CSROAdvocacy) 's Twitter Profile Photo

Frustrated by utilization management issues? Let's tell Congress about it! are invited to join CSRO on 7/10 for live conversations with federal policymakers during our Virtual Advocacy Day. Details & registration at csro.info/conferences/up…

Frustrated by utilization management issues? Let's tell Congress about it! #Rheumatologists are invited to join CSRO on 7/10 for live conversations with federal policymakers during our Virtual Advocacy Day. Details & registration at csro.info/conferences/up…
account_circle
Alex Shteynshlyuger MD(@DrAlexUrology) 's Twitter Profile Photo

It's Official.

The agenda for the May 2024 AMA CPT® Editorial Panel Meeting includes a proposal to establish CPT codes for prior authorization + appeal of wrongful denials.

ama-assn.org/system/files/c…



1/15

It's Official. The agenda for the May 2024 AMA CPT® Editorial Panel Meeting includes a proposal to establish CPT codes for prior authorization + appeal of wrongful denials. ama-assn.org/system/files/c… #PriorAuthCPT #WrongfulDenialAppealCPT 1/15
account_circle
Antonio Ciaccia(@A_Ciaccia) 's Twitter Profile Photo

Was great to attend @TheHill’s Prescribing PBM Reform summit last week and talk shop with some of the brightest minds in the drug policy world. thehill.com/events/4485333…

Was great to attend @TheHill’s Prescribing PBM Reform summit last week and talk shop with some of the brightest minds in the drug policy world. thehill.com/events/4485333…
account_circle
Madelaine Feldman(@MattieRheumMD) 's Twitter Profile Photo

Louisiana's private hospitals are profiting from 340B while vulnerable citizens fall through the cracks in the safety net program. Thank you U.S. Senator Bill Cassidy, M.D. for fighting to bring greater oversight to the program. Patients deserve better. Read more: tinyurl.com/2knpduh9

account_circle
Geisinger Rheumatology(@GeisingerRheum) 's Twitter Profile Photo

A great weekend for the fellows at the CSRO conference in Austin, TX! What an amazing opportunity to catch up with old friends and learn about non-clinical aspects of Rheumatology!!

A great weekend for the fellows at the @CSROAdvocacy conference in Austin, TX! What an amazing opportunity to catch up with old friends and learn about non-clinical aspects of Rheumatology!!
account_circle
Madelaine Feldman(@MattieRheumMD) 's Twitter Profile Photo

One of my slides from PBM talk in 2017. Formulary construction w UM tools - Step Therapy, Non-Medical Switching, egregious Prior Auths &more, makes sure formulary stays profitable.Nothing has changed since then -except many rebates have been reclassified as fees.
CSRO

One of my slides from PBM talk in 2017. Formulary construction w UM tools - Step Therapy, Non-Medical Switching, egregious Prior Auths &more, makes sure formulary stays profitable.Nothing has changed since then -except many rebates have been reclassified as fees. @CSROAdvocacy
account_circle
Nena(@Nenaadvocacy) 's Twitter Profile Photo

Here are the numbers. Indy pharmacies are just not struggling; they are being decimated by the nuclear offenders that r the non-transparent . OFFENDERS LISTED⬇️⬇️⁦CSRO⁩ ⁦Madelaine Feldman⁩ ⁦ ncpa.org/sites/default/…

account_circle